Congenital Insensitivity to Pain

Congenital insensitivity to pain (CIP) is curated here as a phenotype-grouping and navigation entry for rare Mendelian disorders with lifelong absence of protective pain perception from birth. The grouped disorders fall into three broad mechanism classes: developmental nociceptor disorders involving PRDM12 and the NGF-TRKA axis, nociceptor channelopathies involving SCN9A and SCN11A, and transcriptional deregulation within surviving nociceptors in the autosomal dominant ZFHX2 (Marsili) type, where there is no peripheral neuropathy at all. This page intentionally captures only the shared phenotype frame, high-value distinguishing features, and a minimal connected pathograph rather than asserting a single fully unified disease mechanism.

Ask OpenScientist

Ask a research question about Congenital Insensitivity to Pain. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

2
Mappings
11
Pathophys.
6
Phenotypes
23
Pathograph
6
Genes
6
Subtypes
6
References
1
Deep Research
🔗

Mappings

MONDO
MONDO:1060232 congenital insensitivity to pain
skos:exactMatch MONDO
Primary MONDO identifier for this entry. MONDO defines the term as "A rare hereditary sensory and autonomic neuropathy characterized by the inability to perceive physical pain from birth", which is exactly this entry's scope. Its gene-bearing children are the five subtypes this entry already curated (NTRK1, NGF, SCN9A, SCN11A, PRDM12) together with the ZFHX2 Marsili type added in the same pass.
MONDO:0015364 hereditary sensory and autonomic neuropathy DisMech
skos:broadMatch MONDO
The previous `disease_term` binding of this entry, retained as a broader cross-reference. It is the MONDO parent of the exact term above and subsumes the sensory and autonomic neuropathies that are not congenital insensitivity to pain, which this entry does not cover.
◆

Subtypes

6
NTRK1-related HSAN IV / congenital insensitivity to pain with anhidrosis MONDO:0009746
NTRK1 hgnc:8031 HUGO Gene Nomenclature Committee (hgnc) Relation: this subtype is caused by variation in this gene This subtype is caused by variation in NTRK1 (hgnc:8031). hgnc:8031 is a gene from the HUGO Gene Nomenclature Committee.
Classic congenital insensitivity to pain with anhidrosis branch caused by failure of NGF-TRKA-dependent nociceptor and sympathetic development, typically with anhidrosis, recurrent fever, self-injury, and documented intellectual disability in affected cohorts.
Show evidence (2 references)
PMID:16138253 SUPPORT Human Clinical
"Congenital insensitivity to pain with anhidrosis (CIPA) is an autosomal recessive disorder caused by mutations in the neurotrophic tyrosine receptor kinase 1 (NTRK1) gene which encodes the receptor for nerve growth factor (NGF)."
Supports NTRK1 as the canonical HSAN IV / CIPA branch of the CIP grouping.
PMID:16138253 SUPPORT Human Clinical
"They had the characteristic clinical features of an abnormally high pain threshold, and mental retardation;"
Captures intellectual disability as a distinguishing HSAN IV feature.
NGF-related HSAN V MONDO:0012092
NGF hgnc:7808 HUGO Gene Nomenclature Committee (hgnc) Relation: this subtype is caused by variation in this gene This subtype is caused by variation in NGF (hgnc:7808). hgnc:7808 is a gene from the HUGO Gene Nomenclature Committee.
Developmental CIP branch caused by ligand-side disruption of NGF signaling, typically with deep-pain and temperature loss, small-fiber neuropathy, and relatively preserved cognition compared with CIPA.
Show evidence (1 reference)
PMID:14976160 SUPPORT Human Clinical
"Clinically they best fit into HSAN V."
Establishes NGF / NGFB mutation as the cause of the HSAN V branch.
SCN9A-related channelopathy-associated congenital insensitivity to pain MONDO:0009459
SCN9A hgnc:10597 HUGO Gene Nomenclature Committee (hgnc) Relation: this subtype is caused by variation in this gene This subtype is caused by variation in SCN9A (hgnc:10597). hgnc:10597 is a gene from the HUGO Gene Nomenclature Committee.
Nondevelopmental channelopathy branch in which nociceptors are present but Nav1.7 loss of function prevents effective nociceptive signaling; congenital anosmia is the classic associated clue.
Show evidence (1 reference)
PMID:32219415 SUPPORT Other
"The commonest condition within this group is CIP-SCN9A (also called channelopathy associated with CIP). In CIP-SCN9A the only additional feature is congenital anosmia (absence of the sense of smell), and many adults have gone undiagnosed, and/or unbelieved when they explain that they don’t feel pain."
Review evidence supports SCN9A-associated CIP as the major channelopathy subtype and highlights anosmia as its key associated feature.
SCN11A-related HSAN VII / congenital inability to experience pain MONDO:0014244
SCN11A hgnc:10583 HUGO Gene Nomenclature Committee (hgnc) Relation: this subtype is caused by variation in this gene This subtype is caused by variation in SCN11A (hgnc:10583). hgnc:10583 is a gene from the HUGO Gene Nomenclature Committee.
Dominant Nav1.9 channelopathy branch with paradoxical painlessness, gastrointestinal hypomotility, pruritus, mild weakness, and tissue damage caused by gain-of-function depolarization block.
Show evidence (1 reference)
PMID:24036948 SUPPORT Human Clinical
"Using exome sequencing, we identified a specific de novo missense mutation in SCN11A in individuals with the congenital inability to experience pain who suffer from recurrent tissue damage and severe mutilations."
Establishes SCN11A as the cause of the HSAN VII / congenital inability to experience pain branch.
PRDM12-related HSAN VIII / congenital insensitivity to pain-hypohidrosis syndrome MONDO:0014662
PRDM12 hgnc:13997 HUGO Gene Nomenclature Committee (hgnc) Relation: this subtype is caused by variation in this gene This subtype is caused by variation in PRDM12 (hgnc:13997). hgnc:13997 is a gene from the HUGO Gene Nomenclature Committee.
Developmental PRDM12 branch with congenital painlessness from defective nociceptor specification, often with relatively preserved cognition and olfaction compared with classic CIPA. Older reviews may describe this branch as HSAN VI rather than HSAN VIII.
Show evidence (1 reference)
PMID:32219415 SUPPORT Other
"In 2015 a new HSAN4-like phenotype was reported caused by bi-allelic mutations in PRDM12 (clinically known as HSAN6)."
Review evidence establishes PRDM12 as a distinct developmental CIP branch and captures the legacy nomenclature.
ZFHX2-related congenital insensitivity to pain (Marsili syndrome) MONDO:0958106
ZFHX2 hgnc:20152 HUGO Gene Nomenclature Committee (hgnc) Relation: this subtype is caused by variation in this gene This subtype is caused by variation in ZFHX2 (hgnc:20152). hgnc:20152 is a gene from the HUGO Gene Nomenclature Committee.
Autosomal dominant branch, and the only one in this entry that is neither a developmental nociceptor disorder nor a sodium-channel channelopathy. A heterozygous ZFHX2 missense variant segregates with pain insensitivity across three generations of one Italian family, in whom the phenotype is hyposensitivity to noxious heat with painless bone fractures and explicitly no peripheral neuropathy — so the nociceptors are present and the defect is in the transcriptional programme they run.
Show evidence (2 references)
PMID:29253101 SUPPORT Human Clinical
"Here we have analysed an otherwise normal family where six affected individuals display a pain insensitive phenotype that is characterized by hyposensitivity to noxious heat and painless bone fractures."
The clinical description of this subtype: heat hyposensitivity and painless fractures in six affected members of one family.
PMID:29253101 SUPPORT Human Clinical
"This autosomal dominant disorder is found in three generations and is not associated with a peripheral neuropathy."
Establishes autosomal dominant inheritance and the absence of a peripheral neuropathy, which is what separates this subtype from the HSAN branches curated alongside it.
⚙

Pathophysiology

11
Impaired nociceptor specification
PRDM12-related CIP begins as a developmental failure to impose nociceptor identity and precursor differentiation.
Nociceptor CL:0000198 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Nociceptor, annotated with pain receptor cell (CL:0000198). CL:0000198 is a cell type from the Cell Ontology.
PRDM12 hgnc:13997 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves PRDM12 (hgnc:13997). hgnc:13997 is a gene from the HUGO Gene Nomenclature Committee.
neuron development GO:0048666 ⚠ ABNORMAL Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal neuron development (GO:0048666). GO:0048666 is a biological process from the Gene Ontology.
Show evidence (1 reference)
PMID:32219415 SUPPORT Other
"PRDM12 and CLTCL1 are important in the differentiation from a neural crest cell to a precursor sensory neuron."
Supports PRDM12-driven failure of nociceptor specification as an atomic developmental lesion.
NGF-TRKA trophic signaling failure
NTRK1- and NGF-related developmental CIP disrupts the neurotrophin signaling axis needed for nociceptor genesis, maturation, and survival.
Nociceptor CL:0000198 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Nociceptor, annotated with pain receptor cell (CL:0000198). CL:0000198 is a cell type from the Cell Ontology.
NTRK1 hgnc:8031 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves NTRK1 (hgnc:8031). hgnc:8031 is a gene from the HUGO Gene Nomenclature Committee. NGF hgnc:7808 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves NGF (hgnc:7808). hgnc:7808 is a gene from the HUGO Gene Nomenclature Committee.
neurotrophin TRK receptor signaling pathway GO:0048011 ↓ DECREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased neurotrophin TRK receptor signaling pathway (GO:0048011). GO:0048011 is a biological process from the Gene Ontology.
Show evidence (1 reference)
PMID:32219415 SUPPORT Other
"The importance of nerve growth factor-tropomyosin receptor kinase A (NGF-TRKA) signalling for nociceptor genesis and subsequent pain sensing."
Defines the NGF-TRKA axis as the central trophic pathway for developmental CIP.
Developmental nociceptor apoptosis
Developmental CIP converts trophic failure into structural denervation by early loss of nociceptors.
Nociceptor CL:0000198 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Nociceptor, annotated with pain receptor cell (CL:0000198). CL:0000198 is a cell type from the Cell Ontology.
NTRK1 hgnc:8031 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves NTRK1 (hgnc:8031). hgnc:8031 is a gene from the HUGO Gene Nomenclature Committee. NGF hgnc:7808 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves NGF (hgnc:7808). hgnc:7808 is a gene from the HUGO Gene Nomenclature Committee.
apoptotic process GO:0006915 ↑ INCREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased apoptotic process (GO:0006915). GO:0006915 is a biological process from the Gene Ontology.
Show evidence (1 reference)
PMID:32219415 SUPPORT Other
"CIP can be clinically divided into two groups: developmental disorders where nociceptors fail to develop or undergo early apoptosis through lack of trophic signals;"
Supports early nociceptor apoptosis as a distinct downstream event within developmental CIP.
Reduced nociceptor and small-fiber innervation
Developmental CIP forms show reduced C-fiber and A-delta-fiber innervation rather than merely an altered pain threshold.
Nociceptor CL:0000198 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Nociceptor, annotated with pain receptor cell (CL:0000198). CL:0000198 is a cell type from the Cell Ontology.
Show evidence (1 reference)
PMID:14976160 SUPPORT Human Clinical
"A severe reduction of unmyelinated nerve fibers and a moderate loss of thin myelinated nerve fibers are observed in the patients."
Direct pathology evidence that developmental CIP manifests as loss of small pain fibers.
Nav1.7 loss-of-function channelopathy
SCN9A-associated CIP preserves nociceptors anatomically but disables Nav1.7, preventing normal electrical responses to tissue-damage signals.
Nociceptor CL:0000198 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Nociceptor, annotated with pain receptor cell (CL:0000198). CL:0000198 is a cell type from the Cell Ontology.
SCN9A hgnc:10597 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves SCN9A (hgnc:10597). hgnc:10597 is a gene from the HUGO Gene Nomenclature Committee.
regulation of membrane potential GO:0042391 ⚠ ABNORMAL Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal regulation of membrane potential (GO:0042391). GO:0042391 is a biological process from the Gene Ontology.
voltage-gated sodium channel activity GO:0005248 ⇓ LOSS OF FUNCTION Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves voltage-gated sodium channel activity (GO:0005248), qualified as loss of function. GO:0005248 is a molecular function from the Gene Ontology.
Show evidence (1 reference)
PMID:32219415 SUPPORT Other
"So, activating mutations in SCN9A produce paroxysmal neuropathic pain, with no other obvious clinical features. And bi-allelic non-functional mutations cause congenital painlessness, with the only other consequence being anosmia."
Supports SCN9A loss of function as the canonical Nav1.7-related painless channelopathy.
Nav1.9 depolarization-block channelopathy
SCN11A-associated CIP is a paradoxical gain-of-function state in which excessive resting activity of Nav1.9 depolarizes nociceptors and blocks productive action-potential firing.
Nociceptor CL:0000198 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Nociceptor, annotated with pain receptor cell (CL:0000198). CL:0000198 is a cell type from the Cell Ontology.
SCN11A hgnc:10583 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves SCN11A (hgnc:10583). hgnc:10583 is a gene from the HUGO Gene Nomenclature Committee.
membrane depolarization GO:0051899 ⚠ ABNORMAL Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal membrane depolarization (GO:0051899). GO:0051899 is a biological process from the Gene Ontology.
Show evidence (1 reference)
PMID:24036948 SUPPORT Human Clinical
"Mutant Nav1.9 channels displayed excessive activity at resting voltages, causing sustained depolarization of nociceptors, impaired generation of action potentials and aberrant synaptic transmission."
Defines the Nav1.9 depolarization-block mechanism as an atomic SCN11A node.
Impaired nociceptor excitability
In channelopathy-associated CIP, nociceptors are present but electrically unable to generate or propagate appropriate warning signals.
Nociceptor CL:0000198 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Nociceptor, annotated with pain receptor cell (CL:0000198). CL:0000198 is a cell type from the Cell Ontology.
SCN9A hgnc:10597 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves SCN9A (hgnc:10597). hgnc:10597 is a gene from the HUGO Gene Nomenclature Committee. SCN11A hgnc:10583 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves SCN11A (hgnc:10583). hgnc:10583 is a gene from the HUGO Gene Nomenclature Committee.
regulation of membrane potential GO:0042391 ⚠ ABNORMAL Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal regulation of membrane potential (GO:0042391). GO:0042391 is a biological process from the Gene Ontology.
Show evidence (1 reference)
PMID:32219415 SUPPORT Other
"Individuals with second type of CIP are born with nociceptors that are unable to be activated by tissue-damage signals,"
Shared review evidence for the preserved-but-electrically-silent nociceptor model.
Impaired NGF-TRKA-dependent macrophage killing
Developmental NGF-TRKA CIP forms also weaken macrophage-mediated host defense against Staphylococcus aureus.
Macrophage CL:0000235 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Macrophage (CL:0000235). CL:0000235 is a cell type from the Cell Ontology.
NTRK1 hgnc:8031 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves NTRK1 (hgnc:8031). hgnc:8031 is a gene from the HUGO Gene Nomenclature Committee. NGF hgnc:7808 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves NGF (hgnc:7808). hgnc:7808 is a gene from the HUGO Gene Nomenclature Committee.
phagocytosis GO:0006909 ↓ DECREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased phagocytosis (GO:0006909). GO:0006909 is a biological process from the Gene Ontology.
Show evidence (1 reference)
PMID:32219415 SUPPORT Other
"Increased susceptibility to Staphylococcus aureus infection is a consequence of deficient NGF-TRKA signalling."
Supports a distinct macrophage host-defense defect in developmental CIP.
Staphylococcus aureus infection susceptibility
Developmental CIP forms, but not channelopathy-associated forms, show a distinctive propensity to osteomyelitis, septic arthritis, and skin infection with Staphylococcus aureus.
Show evidence (1 reference)
PMID:32219415 SUPPORT Other
"Distinctive to HSANs is a significant susceptibility to Staphylococcus aureus infections manifest as grumbling skin infections, osteomyelitis and septic arthritis."
Captures the clinically important infection susceptibility of developmental CIP forms.
Loss of protective pain perception
Both structural denervation and channelopathic firing failure converge on the same final phenotype: absent protective pain responses with severe injury-related morbidity.
Nociceptor CL:0000198 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Nociceptor, annotated with pain receptor cell (CL:0000198). CL:0000198 is a cell type from the Cell Ontology.
sensory perception of pain GO:0019233 ↓ DECREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased sensory perception of pain (GO:0019233). GO:0019233 is a biological process from the Gene Ontology.
Show evidence (1 reference)
PMID:32219415 SUPPORT Other
"Congenital insensitivity to pain (CIP) is an extremely rare human phenotype where no pain of any type is experienced during an affected individuals’ lifetime."
Defines the shared final phenotype across all grouped CIP branches.
ZFHX2-dependent transcriptional programme deregulation in nociceptors
The Marsili-type lesion. ZFHX2 encodes a transcriptional regulator expressed in small diameter sensory neurons; the homeodomain arginine substitution found in the affected family deregulates expression of genes implicated in peripheral pain mechanisms in dorsal root ganglia. Unlike the PRDM12 and NGF-TRKA branches, the nociceptors themselves are not lost — the reported disorder is explicitly not associated with a peripheral neuropathy — so the claim here is a change in the programme those surviving neurons express.
nociceptor CL:0000198 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves nociceptor, annotated with pain receptor cell (CL:0000198). CL:0000198 is a cell type from the Cell Ontology.
ZFHX2 hgnc:20152 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves ZFHX2 (hgnc:20152). hgnc:20152 is a gene from the HUGO Gene Nomenclature Committee.
regulation of gene expression GO:0010468 ↕ DYSREGULATED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves dysregulated regulation of gene expression (GO:0010468). GO:0010468 is a biological process from the Gene Ontology.
Show evidence (3 references)
PMID:29253101 SUPPORT Model Organism
"Gene expression analyses in dorsal root ganglia from mutant and wild-type mice show altered expression of genes implicated in peripheral pain mechanisms."
The measurement behind this node: mutant dorsal root ganglia show altered expression of pain-related genes, which is the dysregulated gene-expression claim bound here.
PMID:29253101 SUPPORT Human Clinical
"A novel point mutation in ZFHX2, encoding a putative transcription factor expressed in small diameter sensory neurons, was identified by whole exome sequencing that segregates with the pain insensitivity."
Supports the cell type bound on this node — small diameter sensory neurons — and the identity of ZFHX2 as a transcription factor.
PMID:29253101 SUPPORT Human Clinical
"This autosomal dominant disorder is found in three generations and is not associated with a peripheral neuropathy."
Source for the distinction this node draws from the developmental branches: there is no peripheral neuropathy, so the nociceptors are not lost.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Congenital Insensitivity to Pain Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

6
Head and Neck 1
Anosmia HP:0000458 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Anosmia (HP:0000458). HP:0000458 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32219415 SUPPORT Other
"In CIP-SCN9A the only additional feature is congenital anosmia (absence of the sense of smell),"
Supports anosmia as the distinguishing SCN9A-associated phenotype.
Immune 1
Osteomyelitis HP:0002754 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Osteomyelitis (HP:0002754). HP:0002754 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32219415 SUPPORT Other
"Distinctive to HSANs is a significant susceptibility to Staphylococcus aureus infections manifest as grumbling skin infections, osteomyelitis and septic arthritis."
Captures osteomyelitis as a distinctive complication of developmental CIP branches.
Musculoskeletal 1
Neuropathic arthropathy HP:0002821 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Neuropathic arthropathy (Charcot joint), annotated with Neuropathic arthropathy (HP:0002821). HP:0002821 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32219415 SUPPORT Other
"Long bone fractures can heal, if allowed to do so, but it is the joint injuries that inevitably lead to Charcot’s joints, and hence progressive orthopaedic deformities."
Supports Charcot-joint arthropathy as a shared morbidity of CIP.
Nervous System 3
Pain insensitivity HP:0007021 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Congenital insensitivity to pain, annotated with Pain insensitivity (HP:0007021). HP:0007021 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32219415 SUPPORT Other
"Congenital insensitivity to pain (CIP) is an extremely rare human phenotype where no pain of any type is experienced during an affected individuals’ lifetime."
Supports the core umbrella phenotype of absent pain sensation.
Self-mutilation HP:0000742 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Self-mutilation (HP:0000742). HP:0000742 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32219415 SUPPORT Other
"Coincident with teething in the first year of life, self-mutilation of lips, tongue, fingers and toes often occur."
Supports self-injury as a recurrent shared consequence of CIP.
Intellectual disability HP:0001249 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Intellectual disability (HP:0001249). HP:0001249 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:16138253 SUPPORT Human Clinical
"They had the characteristic clinical features of an abnormally high pain threshold, and mental retardation;"
Supports intellectual disability as a documented HSAN IV feature.
🧬

Genetic Associations

6
NTRK1 (Causative)
Gene: NTRK1 hgnc:8031 gene page HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is NTRK1 (hgnc:8031). hgnc:8031 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE variant_origin: GERMLINE
Show evidence (1 reference)
PMID:16138253 SUPPORT Human Clinical
"Congenital insensitivity to pain with anhidrosis (CIPA) is an autosomal recessive disorder caused by mutations in the neurotrophic tyrosine receptor kinase 1 (NTRK1) gene which encodes the receptor for nerve growth factor (NGF)."
Direct human evidence that NTRK1 mutations cause the HSAN IV / CIPA branch.
NGF (Causative)
Gene: NGF hgnc:7808 gene page HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is NGF (hgnc:7808). hgnc:7808 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE variant_origin: GERMLINE
Show evidence (2 references)
PMID:14976160 SUPPORT Human Clinical
"Clinically they best fit into HSAN V."
Direct evidence that NGF mutation causes the HSAN V form of CIP.
"NGF | HGNC:7808 | hereditary sensory and autonomic neuropathy | MONDO:0015364 | AR | Strong"
ClinGen classifies the NGF-hereditary sensory and autonomic neuropathy gene-disease relationship as strong with autosomal recessive inheritance.
SCN9A (Causative)
Gene: SCN9A hgnc:10597 gene page HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is SCN9A (hgnc:10597). hgnc:10597 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE variant_origin: GERMLINE
Show evidence (1 reference)
PMID:32219415 SUPPORT Other
"So, activating mutations in SCN9A produce paroxysmal neuropathic pain, with no other obvious clinical features. And bi-allelic non-functional mutations cause congenital painlessness, with the only other consequence being anosmia."
Review evidence distinguishes the painless SCN9A loss-of-function phenotype from painful SCN9A gain-of-function disorders.
SCN11A (Causative)
Gene: SCN11A hgnc:10583 gene page HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is SCN11A (hgnc:10583). hgnc:10583 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE variant_origin: GERMLINE
Show evidence (2 references)
PMID:24036948 SUPPORT Human Clinical
"Using exome sequencing, we identified a specific de novo missense mutation in SCN11A in individuals with the congenital inability to experience pain who suffer from recurrent tissue damage and severe mutilations."
Human genetic evidence establishing SCN11A as a cause of congenital painlessness.
PMID:24036948 SUPPORT Human Clinical
"Mutant Nav1.9 channels displayed excessive activity at resting voltages, causing sustained depolarization of nociceptors, impaired generation of action potentials and aberrant synaptic transmission."
Functional evidence shows why SCN11A gain of function produces painlessness rather than pain.
PRDM12 (Causative)
Gene: PRDM12 hgnc:13997 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is PRDM12 (hgnc:13997). hgnc:13997 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE variant_origin: GERMLINE
Show evidence (2 references)
PMID:32219415 SUPPORT Other
"In 2015 a new HSAN4-like phenotype was reported caused by bi-allelic mutations in PRDM12 (clinically known as HSAN6)."
Review evidence establishes PRDM12 as a distinct developmental CIP gene.
PMID:32219415 SUPPORT Other
"The recent finding that PRDM12 activated NTRK1 expression in nociceptor precursors further cemented the absolute importance of NGF-TRKA signalling for nociceptor genesis."
Supports PRDM12 as an upstream nociceptor-specification regulator linked mechanistically to the NGF-TRKA program.
ZFHX2 (Causal)
Gene: ZFHX2 hgnc:20152 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is ZFHX2 (hgnc:20152). hgnc:20152 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE variant_origin: GERMLINE
Show evidence (3 references)
PMID:29253101 SUPPORT Human Clinical
"A novel point mutation in ZFHX2, encoding a putative transcription factor expressed in small diameter sensory neurons, was identified by whole exome sequencing that segregates with the pain insensitivity."
The human genetic evidence: a ZFHX2 point mutation segregating with the pain-insensitive phenotype, in a gene expressed in small diameter sensory neurons.
PMID:29253101 SUPPORT Human Clinical
"The mutation is predicted to change an evolutionarily highly conserved arginine residue 1913 to a lysine within a homeodomain."
Identifies the variant as a homeodomain arginine substitution, the basis for treating it as a change in ZFHX2's transcriptional function.
PMID:29253101 SUPPORT Model Organism
"Bacterial artificial chromosome (BAC) transgenic mice bearing the orthologous murine p.R1907K mutation, as well as Zfhx2 null mutant mice, have significant deficits in pain sensitivity."
Two independent mouse genotypes reproduce the pain-sensitivity deficit, which is the non-human support this single-family association rests on.
{ }

Source YAML

click to show
name: Congenital Insensitivity to Pain
creation_date: "2026-04-16T19:22:23Z"
category: Mendelian
synonyms:
- CIP
- congenital analgesia
- congenital painlessness
description: >-
  Congenital insensitivity to pain (CIP) is curated here as a phenotype-grouping
  and navigation entry for rare Mendelian disorders with lifelong absence of
  protective pain perception from birth. The grouped disorders fall into three
  broad mechanism classes: developmental nociceptor disorders involving PRDM12
  and the NGF-TRKA axis, nociceptor channelopathies involving SCN9A and SCN11A,
  and transcriptional deregulation within surviving nociceptors in the autosomal
  dominant ZFHX2 (Marsili) type, where there is no peripheral neuropathy at all.
  This page intentionally captures only the shared phenotype frame,
  high-value distinguishing features, and a minimal connected pathograph rather
  than asserting a single fully unified disease mechanism.
disease_term:
  preferred_term: congenital insensitivity to pain
  term:
    id: MONDO:1060232
    label: congenital insensitivity to pain
mappings:
  mondo_mappings:
  - term:
      id: MONDO:1060232
      label: congenital insensitivity to pain
    mapping_predicate: skos:exactMatch
    mapping_source: MONDO
    mapping_justification: >-
      Primary MONDO identifier for this entry. MONDO defines the term as "A rare
      hereditary sensory and autonomic neuropathy characterized by the inability
      to perceive physical pain from birth", which is exactly this entry's scope.
      Its gene-bearing children are the five subtypes this entry already curated
      (NTRK1, NGF, SCN9A, SCN11A, PRDM12) together with the ZFHX2 Marsili type
      added in the same pass.
  - term:
      id: MONDO:0015364
      label: hereditary sensory and autonomic neuropathy
    mapping_predicate: skos:broadMatch
    mapping_source: MONDO
    mapping_justification: >-
      The previous `disease_term` binding of this entry, retained as a broader
      cross-reference. It is the MONDO parent of the exact term above and
      subsumes the sensory and autonomic neuropathies that are not congenital
      insensitivity to pain, which this entry does not cover.
notes: >-
  GeneReviews baseline: two chapters cover this entry's scope and are now listed
  in `references:` - the `Congenital Insensitivity to Pain Overview`
  (PMID:29419974), which matches this entry's name exactly, and
  `NTRK1 Congenital Insensitivity to Pain with Anhidrosis` (PMID:20301726) for
  the HSAN IV branch. Neither is quoted as evidence: only their abstracts are
  cached, and the overview's abstract is a statement of the chapter's purpose
  rather than a finding, so there is no propositional sentence in the cached
  text to quote. They are recorded as the baseline this entry should be mined
  against when full text becomes available.

  MONDO anchor. An earlier revision of this entry recorded that no MONDO term
  for "congenital insensitivity to pain" existed and anchored to the broader
  hereditary sensory and autonomic neuropathy parent instead. That is no longer
  the case: `runoak -i ols:mondo search 'congenital insensitivity to pain'`
  returns `MONDO:1060232 congenital insensitivity to pain` as its first hit, and
  `MONDO:1060232` is now this entry's `disease_term`. The previous anchor
  `MONDO:0015364` is kept as a `skos:broadMatch` cross-reference. Subtype-specific
  mechanistic and management detail should still ultimately live in dedicated
  child entries.

  Series completeness under the exact term. `MONDO:1060232` has eight
  hierarchical descendants. Six are curated here as `has_subtypes` rows:
  `MONDO:0009746` (HSAN IV, NTRK1), `MONDO:0012092` (HSAN V, NGF),
  `MONDO:0009459` (SCN9A channelopathy-associated CIP), `MONDO:0014244`
  (HSAN VII, SCN11A), `MONDO:0014662` (CIP-hypohidrosis, PRDM12) and
  `MONDO:0958106` (Marsili type, ZFHX2). The remaining two carry no causal gene
  in MONDO and are not curated: `MONDO:0016319` congenital insensitivity to pain
  with hyperhidrosis and `MONDO:0018682` congenital insensitivity to pain with
  severe intellectual disability. Each is named after an additional clinical
  feature rather than a gene, and each is xrefed only to Orphanet and MedGen with
  no OMIM entry, so there is no gene for this pass to wire; they are recorded
  here so the gap is visible rather than silent.

  Genes moved out by the re-anchoring. The previous broad anchor pulled in a
  RETREG1 `genetic:` record whose own notes said it should move rather than be
  duplicated if this entry were ever re-anchored on a true
  congenital-insensitivity-to-pain class. RETREG1 is the HSAN2B gene and is
  already curated at the right granularity as an HSAN2B `has_subtypes` row with
  its own `genetic:` record on Hereditary Sensory and Autonomic Neuropathy Type 2,
  so the record here has been removed rather than rewritten. The ClinGen
  assertion it carried is made against `MONDO:0015364`, which is now only a
  `skos:broadMatch` cross-reference on this entry.

  Diseases the previous broad anchor also reached, and why they are not curated
  here. Cold-induced sweating syndrome 1 (`MONDO:0010091`, CRLF1) and 2
  (`MONDO:0012467`, CLCF1), PERCHING syndrome (`MONDO:0014890`, KLHL7),
  hereditary sensory and autonomic neuropathy type 1A (`MONDO:0008086`, SPTLC1)
  and hereditary sensory neuropathy type 1F (`MONDO:0014286`, ATL3) are all
  hierarchical descendants of `MONDO:0015364`; none is a descendant of
  `MONDO:1060232`, and none is congenital insensitivity to pain. MONDO files the
  first three under `MONDO:0015526 cold-induced sweating syndrome`, and defines
  CISS1 as "a severe disorder characterized by muscular contractions at birth,
  intermittent hyperthermia, facial abnormalities and camptodactyly" — a
  phenotype that does not include absence of pain. PERCHING is a multisystem
  KLHL7 syndrome whose MONDO definition enumerates postural, palatal, ocular,
  respiratory, contractural, growth and feeding features, and it has an open
  stub (`stubs/PERCHING_Syndrome.yaml`) rather than a home here; MONDO's placement
  of it under cold-induced sweating syndrome is itself worth checking upstream.
  HSAN1A and HSN1F both sit under `MONDO:0018213 hereditary sensory and autonomic
  neuropathy type 1`, a separate series this KB curates in its own entries:
  HSAN1A is already curated as Hereditary Sensory and Autonomic Neuropathy
  Type 1A on `MONDO:0008086`, and HSN1F belongs beside the other HSN1 atlastin
  form, Hereditary Sensory Neuropathy Type 1D (ATL1).
review_notes: >-
  This revision intentionally hard-trims the prior umbrella into a navigation
  entry: the shared phenotype frame is retained, the pathophysiology nodes are
  now atomic and connected, and subtype-specific distinguishing findings are
  captured without pretending that all grouped branches constitute one cleanly
  unified disease entity.
references:
- reference: PMID:29419974
  title: "Congenital Insensitivity to Pain Overview."
  tags:
  - GeneReviews
- reference: PMID:20301726
  title: "NTRK1 Congenital Insensitivity to Pain with Anhidrosis."
  tags:
  - GeneReviews
- reference: PMID:32219415
  title: "Understanding the genetic basis of congenital insensitivity to pain."
  found_in:
  - Congenital_Insensitivity_to_Pain-deep-research-manual.md
  findings:
  - statement: >-
      Congenital insensitivity to pain (CIP) is caused by extremely rare
      Mendelian genetic disorders.
    supporting_text: >-
      Congenital insensitivity to pain (CIP) is caused by extremely rare
      Mendelian genetic disorders.
- reference: PMID:16138253
  title: >-
    Congenital insensitivity to pain with Anhidrosis (NTRK1 mutation) and early
    onset renal disease: clinical report on three sibs with a 25-year follow-up
    in one of them.
  found_in:
  - Congenital_Insensitivity_to_Pain-deep-research-manual.md
  findings:
  - statement: >-
      Congenital insensitivity to pain with anhidrosis (CIPA) is an autosomal
      recessive disorder caused by mutations in the neurotrophic tyrosine
      receptor kinase 1 (NTRK1) gene which encodes the receptor for nerve
      growth factor (NGF).
    supporting_text: >-
      Congenital insensitivity to pain with anhidrosis (CIPA) is an autosomal
      recessive disorder caused by mutations in the neurotrophic tyrosine
      receptor kinase 1 (NTRK1) gene which encodes the receptor for nerve
      growth factor (NGF).
- reference: PMID:14976160
  title: >-
    A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain
    perception.
  found_in:
  - Congenital_Insensitivity_to_Pain-deep-research-manual.md
  findings:
  - statement: >-
      Clinically they best fit into HSAN V.
    supporting_text: >-
      Clinically they best fit into HSAN V.
- reference: PMID:24036948
  title: >-
    A de novo gain-of-function mutation in SCN11A causes loss of pain
    perception.
  found_in:
  - Congenital_Insensitivity_to_Pain-deep-research-manual.md
  findings:
  - statement: >-
      Using exome sequencing, we identified a specific de novo missense
      mutation in SCN11A in individuals with the congenital inability to
      experience pain who suffer from recurrent tissue damage and severe
      mutilations.
    supporting_text: >-
      Using exome sequencing, we identified a specific de novo missense
      mutation in SCN11A in individuals with the congenital inability to
      experience pain who suffer from recurrent tissue damage and severe
      mutilations.
has_subtypes:
- name: HSAN IV
  display_name: NTRK1-related HSAN IV / congenital insensitivity to pain with anhidrosis
  subtype_term:
    preferred_term: hereditary sensory and autonomic neuropathy type 4
    term:
      id: MONDO:0009746
      label: hereditary sensory and autonomic neuropathy type 4
  description: >-
    Classic congenital insensitivity to pain with anhidrosis branch caused by
    failure of NGF-TRKA-dependent nociceptor and sympathetic development,
    typically with anhidrosis, recurrent fever, self-injury, and documented
    intellectual disability in affected cohorts.
  evidence:
  - reference: PMID:16138253
    reference_title: >-
      Congenital insensitivity to pain with Anhidrosis (NTRK1 mutation) and
      early onset renal disease: clinical report on three sibs with a 25-year
      follow-up in one of them.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Congenital insensitivity to pain with anhidrosis (CIPA) is an autosomal
      recessive disorder caused by mutations in the neurotrophic tyrosine
      receptor kinase 1 (NTRK1) gene which encodes the receptor for nerve
      growth factor (NGF).
    explanation: Supports NTRK1 as the canonical HSAN IV / CIPA branch of the CIP grouping.
  - reference: PMID:16138253
    reference_title: >-
      Congenital insensitivity to pain with Anhidrosis (NTRK1 mutation) and
      early onset renal disease: clinical report on three sibs with a 25-year
      follow-up in one of them.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      They had the characteristic clinical features of an abnormally high pain
      threshold, and mental retardation;
    explanation: Captures intellectual disability as a distinguishing HSAN IV feature.
  genes:
  - preferred_term: NTRK1
    term:
      id: hgnc:8031
      label: NTRK1
- name: HSAN V
  display_name: NGF-related HSAN V
  subtype_term:
    preferred_term: hereditary sensory and autonomic neuropathy type 5
    term:
      id: MONDO:0012092
      label: hereditary sensory and autonomic neuropathy type 5
  description: >-
    Developmental CIP branch caused by ligand-side disruption of NGF signaling,
    typically with deep-pain and temperature loss, small-fiber neuropathy, and
    relatively preserved cognition compared with CIPA.
  evidence:
  - reference: PMID:14976160
    reference_title: "A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Clinically they best fit into HSAN V.
    explanation: Establishes NGF / NGFB mutation as the cause of the HSAN V branch.
  genes:
  - preferred_term: NGF
    term:
      id: hgnc:7808
      label: NGF
- name: SCN9A AR-CIP
  display_name: SCN9A-related channelopathy-associated congenital insensitivity to pain
  subtype_term:
    preferred_term: channelopathy-associated congenital insensitivity to pain, autosomal recessive
    term:
      id: MONDO:0009459
      label: channelopathy-associated congenital insensitivity to pain, autosomal recessive
  description: >-
    Nondevelopmental channelopathy branch in which nociceptors are present but
    Nav1.7 loss of function prevents effective nociceptive signaling;
    congenital anosmia is the classic associated clue.
  evidence:
  - reference: PMID:32219415
    reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The commonest condition within this group is CIP-SCN9A (also called
      channelopathy associated with CIP). In CIP-SCN9A the only additional
      feature is congenital anosmia (absence of the sense of smell), and many
      adults have gone undiagnosed, and/or unbelieved when they explain that
      they don’t feel pain.
    explanation: Review evidence supports SCN9A-associated CIP as the major channelopathy subtype and highlights anosmia as its key associated feature.
  genes:
  - preferred_term: SCN9A
    term:
      id: hgnc:10597
      label: SCN9A
- name: HSAN VII
  display_name: SCN11A-related HSAN VII / congenital inability to experience pain
  subtype_term:
    preferred_term: hereditary sensory and autonomic neuropathy type 7
    term:
      id: MONDO:0014244
      label: hereditary sensory and autonomic neuropathy type 7
  description: >-
    Dominant Nav1.9 channelopathy branch with paradoxical painlessness,
    gastrointestinal hypomotility, pruritus, mild weakness, and tissue damage
    caused by gain-of-function depolarization block.
  evidence:
  - reference: PMID:24036948
    reference_title: "A de novo gain-of-function mutation in SCN11A causes loss of pain perception."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Using exome sequencing, we identified a specific de novo missense
      mutation in SCN11A in individuals with the congenital inability to
      experience pain who suffer from recurrent tissue damage and severe
      mutilations.
    explanation: Establishes SCN11A as the cause of the HSAN VII / congenital inability to experience pain branch.
  genes:
  - preferred_term: SCN11A
    term:
      id: hgnc:10583
      label: SCN11A
- name: HSAN VIII
  display_name: PRDM12-related HSAN VIII / congenital insensitivity to pain-hypohidrosis syndrome
  subtype_term:
    preferred_term: congenital insensitivity to pain-hypohidrosis syndrome
    term:
      id: MONDO:0014662
      label: congenital insensitivity to pain-hypohidrosis syndrome
  description: >-
    Developmental PRDM12 branch with congenital painlessness from defective
    nociceptor specification, often with relatively preserved cognition and
    olfaction compared with classic CIPA. Older reviews may describe this
    branch as HSAN VI rather than HSAN VIII.
  evidence:
  - reference: PMID:32219415
    reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      In 2015 a new HSAN4-like phenotype was reported caused by bi-allelic
      mutations in PRDM12 (clinically known as HSAN6).
    explanation: Review evidence establishes PRDM12 as a distinct developmental CIP branch and captures the legacy nomenclature.
  genes:
  - preferred_term: PRDM12
    term:
      id: hgnc:13997
      label: PRDM12
- name: Marsili type
  display_name: ZFHX2-related congenital insensitivity to pain (Marsili syndrome)
  subtype_term:
    preferred_term: congenital insensitivity to pain syndrome, Marsili type
    term:
      id: MONDO:0958106
      label: congenital insensitivity to pain syndrome, Marsili type
  description: >-
    Autosomal dominant branch, and the only one in this entry that is neither a
    developmental nociceptor disorder nor a sodium-channel channelopathy. A
    heterozygous ZFHX2 missense variant segregates with pain insensitivity across
    three generations of one Italian family, in whom the phenotype is
    hyposensitivity to noxious heat with painless bone fractures and explicitly
    no peripheral neuropathy — so the nociceptors are present and the defect is
    in the transcriptional programme they run.
  genes:
  - preferred_term: ZFHX2
    term:
      id: hgnc:20152
      label: ZFHX2
  evidence:
  - reference: PMID:29253101
    reference_title: A novel human pain insensitivity disorder caused by a point mutation in ZFHX2.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Here we have analysed an otherwise normal family where six affected individuals display a pain insensitive phenotype that is characterized by hyposensitivity to noxious heat and painless bone fractures."
    explanation: >-
      The clinical description of this subtype: heat hyposensitivity and painless
      fractures in six affected members of one family.
  - reference: PMID:29253101
    reference_title: A novel human pain insensitivity disorder caused by a point mutation in ZFHX2.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This autosomal dominant disorder is found in three generations and is not associated with a peripheral neuropathy."
    explanation: >-
      Establishes autosomal dominant inheritance and the absence of a peripheral
      neuropathy, which is what separates this subtype from the HSAN branches
      curated alongside it.
genetic:
- name: NTRK1
  gene_term:
    preferred_term: NTRK1
    term:
      id: hgnc:8031
      label: NTRK1
  association: Causative
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  subtype: HSAN IV
  features: >-
    Biallelic NTRK1 variants define the classic HSAN IV / CIPA branch within
    this grouped phenotype entry.
  evidence:
  - reference: PMID:16138253
    reference_title: >-
      Congenital insensitivity to pain with Anhidrosis (NTRK1 mutation) and
      early onset renal disease: clinical report on three sibs with a 25-year
      follow-up in one of them.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Congenital insensitivity to pain with anhidrosis (CIPA) is an autosomal
      recessive disorder caused by mutations in the neurotrophic tyrosine
      receptor kinase 1 (NTRK1) gene which encodes the receptor for nerve
      growth factor (NGF).
    explanation: Direct human evidence that NTRK1 mutations cause the HSAN IV / CIPA branch.
- name: NGF
  gene_term:
    preferred_term: NGF
    term:
      id: hgnc:7808
      label: NGF
  association: Causative
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  subtype: HSAN V
  features: >-
    Homozygous NGF variants define the HSAN V branch and show that ligand-side
    disruption of the same trophic axis can produce congenital painlessness.
  evidence:
  - reference: PMID:14976160
    reference_title: "A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Clinically they best fit into HSAN V.
    explanation: Direct evidence that NGF mutation causes the HSAN V form of CIP.
  - reference: CGGV:assertion_f0b3691d-a3d3-42f6-9703-18af08f40688-2023-05-05T160000.000Z
    reference_title: "NGF / hereditary sensory and autonomic neuropathy (Strong)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "NGF | HGNC:7808 | hereditary sensory and autonomic neuropathy | MONDO:0015364 | AR | Strong"
    explanation: ClinGen classifies the NGF-hereditary sensory and autonomic neuropathy gene-disease relationship as strong with autosomal recessive inheritance.
- name: SCN9A
  gene_term:
    preferred_term: SCN9A
    term:
      id: hgnc:10597
      label: SCN9A
  association: Causative
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  subtype: SCN9A AR-CIP
  features: >-
    Biallelic SCN9A loss-of-function variants cause channelopathy-associated
    CIP with anosmia and preserved nociceptor anatomy.
  evidence:
  - reference: PMID:32219415
    reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      So, activating mutations in SCN9A produce paroxysmal neuropathic pain,
      with no other obvious clinical features. And bi-allelic non-functional
      mutations cause congenital painlessness, with the only other consequence
      being anosmia.
    explanation: Review evidence distinguishes the painless SCN9A loss-of-function phenotype from painful SCN9A gain-of-function disorders.
- name: SCN11A
  gene_term:
    preferred_term: SCN11A
    term:
      id: hgnc:10583
      label: SCN11A
  association: Causative
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  subtype: HSAN VII
  features: >-
    Dominant SCN11A gain-of-function variants cause a paradoxical painless
    channelopathy by sustaining depolarization and blocking nociceptor firing.
  evidence:
  - reference: PMID:24036948
    reference_title: "A de novo gain-of-function mutation in SCN11A causes loss of pain perception."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Using exome sequencing, we identified a specific de novo missense
      mutation in SCN11A in individuals with the congenital inability to
      experience pain who suffer from recurrent tissue damage and severe
      mutilations.
    explanation: Human genetic evidence establishing SCN11A as a cause of congenital painlessness.
  - reference: PMID:24036948
    reference_title: "A de novo gain-of-function mutation in SCN11A causes loss of pain perception."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Mutant Nav1.9 channels displayed excessive activity at resting voltages,
      causing sustained depolarization of nociceptors, impaired generation of
      action potentials and aberrant synaptic transmission.
    explanation: Functional evidence shows why SCN11A gain of function produces painlessness rather than pain.
- name: PRDM12
  gene_term:
    preferred_term: PRDM12
    term:
      id: hgnc:13997
      label: PRDM12
  association: Causative
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  subtype: HSAN VIII
  features: >-
    Biallelic PRDM12 variants define a developmental CIP branch by impairing
    nociceptor specification upstream of the NGF-TRKA program.
  evidence:
  - reference: PMID:32219415
    reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      In 2015 a new HSAN4-like phenotype was reported caused by bi-allelic
      mutations in PRDM12 (clinically known as HSAN6).
    explanation: Review evidence establishes PRDM12 as a distinct developmental CIP gene.
  - reference: PMID:32219415
    reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The recent finding that PRDM12 activated NTRK1 expression in nociceptor
      precursors further cemented the absolute importance of NGF-TRKA
      signalling for nociceptor genesis.
    explanation: Supports PRDM12 as an upstream nociceptor-specification regulator linked mechanistically to the NGF-TRKA program.
- name: ZFHX2
  gene_term:
    preferred_term: ZFHX2
    term:
      id: hgnc:20152
      label: ZFHX2
  association: Causal
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  subtype: Marsili type
  notes: >-
    Zinc finger homeobox 2, a transcriptional regulator expressed in small
    diameter sensory neurons. A single heterozygous missense variant changing a
    conserved arginine within a homeodomain segregates with pain insensitivity in
    the reported family; mice carrying the orthologous change and Zfhx2 null mice
    both show pain-sensitivity deficits. The human evidence is one family, so this
    record rests on segregation plus two mouse models rather than on independent
    human replication.
  evidence:
  - reference: PMID:29253101
    reference_title: A novel human pain insensitivity disorder caused by a point mutation in ZFHX2.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A novel point mutation in ZFHX2, encoding a putative transcription factor expressed in small diameter sensory neurons, was identified by whole exome sequencing that segregates with the pain insensitivity."
    explanation: >-
      The human genetic evidence: a ZFHX2 point mutation segregating with the
      pain-insensitive phenotype, in a gene expressed in small diameter sensory
      neurons.
  - reference: PMID:29253101
    reference_title: A novel human pain insensitivity disorder caused by a point mutation in ZFHX2.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The mutation is predicted to change an evolutionarily highly conserved arginine residue 1913 to a lysine within a homeodomain."
    explanation: >-
      Identifies the variant as a homeodomain arginine substitution, the basis for
      treating it as a change in ZFHX2's transcriptional function.
  - reference: PMID:29253101
    reference_title: A novel human pain insensitivity disorder caused by a point mutation in ZFHX2.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Bacterial artificial chromosome (BAC) transgenic mice bearing the orthologous murine p.R1907K mutation, as well as Zfhx2 null mutant mice, have significant deficits in pain sensitivity."
    explanation: >-
      Two independent mouse genotypes reproduce the pain-sensitivity deficit,
      which is the non-human support this single-family association rests on.
pathophysiology:
- name: Impaired nociceptor specification
  description: >-
    PRDM12-related CIP begins as a developmental failure to impose nociceptor
    identity and precursor differentiation.
  genes:
  - preferred_term: PRDM12
    term:
      id: hgnc:13997
      label: PRDM12
  cell_types:
  - preferred_term: Nociceptor
    term:
      id: CL:0000198
      label: pain receptor cell
  biological_processes:
  - preferred_term: neuron development
    modifier: ABNORMAL
    term:
      id: GO:0048666
      label: neuron development
  evidence:
  - reference: PMID:32219415
    reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      PRDM12 and CLTCL1 are important in the differentiation from a neural
      crest cell to a precursor sensory neuron.
    explanation: Supports PRDM12-driven failure of nociceptor specification as an atomic developmental lesion.
  downstream:
  - target: NGF-TRKA trophic signaling failure
    description: >-
      Reduced PRDM12 activity impairs the developmental program that normally
      establishes NTRK1 expression in nociceptor precursors.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:32219415
      reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        The recent finding that PRDM12 activated NTRK1 expression in
        nociceptor precursors further cemented the absolute importance of
        NGF-TRKA signalling for nociceptor genesis.
      explanation: Directly connects PRDM12-dependent specification to the NGF-TRKA trophic axis.
- name: NGF-TRKA trophic signaling failure
  description: >-
    NTRK1- and NGF-related developmental CIP disrupts the neurotrophin signaling
    axis needed for nociceptor genesis, maturation, and survival.
  genes:
  - preferred_term: NTRK1
    term:
      id: hgnc:8031
      label: NTRK1
  - preferred_term: NGF
    term:
      id: hgnc:7808
      label: NGF
  cell_types:
  - preferred_term: Nociceptor
    term:
      id: CL:0000198
      label: pain receptor cell
  biological_processes:
  - preferred_term: neurotrophin TRK receptor signaling pathway
    modifier: DECREASED
    term:
      id: GO:0048011
      label: neurotrophin TRK receptor signaling pathway
  evidence:
  - reference: PMID:32219415
    reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The importance of nerve growth factor-tropomyosin receptor kinase A
      (NGF-TRKA) signalling for nociceptor genesis and subsequent pain
      sensing.
    explanation: Defines the NGF-TRKA axis as the central trophic pathway for developmental CIP.
  downstream:
  - target: Developmental nociceptor apoptosis
    description: >-
      Failure of trophic support causes early nociceptor loss during
      development.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:32219415
      reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        CIP can be clinically divided into two groups: developmental disorders
        where nociceptors fail to develop or undergo early apoptosis through
        lack of trophic signals;
      explanation: Directly links trophic signaling failure to developmental nociceptor apoptosis.
  - target: Impaired NGF-TRKA-dependent macrophage killing
    description: >-
      The same pathway also contributes to macrophage antibacterial responses,
      explaining infection susceptibility in developmental CIP forms.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:32219415
      reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Increased susceptibility to Staphylococcus aureus infection is a
        consequence of deficient NGF-TRKA signalling.
      explanation: Directly connects deficient NGF-TRKA signaling to impaired host defense.
  - target: Intellectual disability
    description: >-
      NTRK1-related CIPA includes intellectual disability as part of the
      developmental HSAN IV phenotype; the intervening CNS mechanism is not
      resolved in this umbrella entry.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:16138253
      reference_title: >-
        Congenital insensitivity to pain with Anhidrosis (NTRK1 mutation) and
        early onset renal disease: clinical report on three sibs with a 25-year
        follow-up in one of them.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        They had the characteristic clinical features of an abnormally high pain
        threshold, and mental retardation;
      explanation: >-
        The NTRK1-related CIPA sibling report documents mental retardation
        alongside the pain-insensitivity phenotype, supporting the branch-level
        link to intellectual disability.
- name: Developmental nociceptor apoptosis
  description: >-
    Developmental CIP converts trophic failure into structural denervation by
    early loss of nociceptors.
  genes:
  - preferred_term: NTRK1
    term:
      id: hgnc:8031
      label: NTRK1
  - preferred_term: NGF
    term:
      id: hgnc:7808
      label: NGF
  cell_types:
  - preferred_term: Nociceptor
    term:
      id: CL:0000198
      label: pain receptor cell
  biological_processes:
  - preferred_term: apoptotic process
    modifier: INCREASED
    term:
      id: GO:0006915
      label: apoptotic process
  evidence:
  - reference: PMID:32219415
    reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      CIP can be clinically divided into two groups: developmental disorders
      where nociceptors fail to develop or undergo early apoptosis through
      lack of trophic signals;
    explanation: Supports early nociceptor apoptosis as a distinct downstream event within developmental CIP.
  downstream:
  - target: Reduced nociceptor and small-fiber innervation
    description: >-
      Early apoptosis yields the characteristic loss of pain-transducing small
      fibers in developmental CIP.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:14976160
      reference_title: "A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        A severe reduction of unmyelinated nerve fibers and a moderate loss of
        thin myelinated nerve fibers are observed in the patients.
      explanation: Links developmental nociceptor loss to the small-fiber deficit seen in HSAN V.
- name: Reduced nociceptor and small-fiber innervation
  description: >-
    Developmental CIP forms show reduced C-fiber and A-delta-fiber innervation
    rather than merely an altered pain threshold.
  cell_types:
  - preferred_term: Nociceptor
    term:
      id: CL:0000198
      label: pain receptor cell
  evidence:
  - reference: PMID:14976160
    reference_title: "A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A severe reduction of unmyelinated nerve fibers and a moderate loss of
      thin myelinated nerve fibers are observed in the patients.
    explanation: Direct pathology evidence that developmental CIP manifests as loss of small pain fibers.
  downstream:
  - target: Loss of protective pain perception
    description: >-
      Structural denervation removes the afferent substrate required for normal
      pain sensing.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:32219415
      reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Congenital insensitivity to pain (CIP) is an extremely rare human
        phenotype where no pain of any type is experienced during an affected
        individuals’ lifetime.
      explanation: Connects reduced pain-fiber innervation to the shared analgesic phenotype.
- name: Nav1.7 loss-of-function channelopathy
  conforms_to: "nociceptor_sodium_channel_excitability#Loss of Nociceptor Sodium Current"
  description: >-
    SCN9A-associated CIP preserves nociceptors anatomically but disables Nav1.7,
    preventing normal electrical responses to tissue-damage signals.
  genes:
  - preferred_term: SCN9A
    term:
      id: hgnc:10597
      label: SCN9A
  cell_types:
  - preferred_term: Nociceptor
    term:
      id: CL:0000198
      label: pain receptor cell
  molecular_functions:
  - preferred_term: voltage-gated sodium channel activity
    modifier: LOSS_OF_FUNCTION
    term:
      id: GO:0005248
      label: voltage-gated sodium channel activity
  biological_processes:
  - preferred_term: regulation of membrane potential
    modifier: ABNORMAL
    term:
      id: GO:0042391
      label: regulation of membrane potential
  evidence:
  - reference: PMID:32219415
    reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      So, activating mutations in SCN9A produce paroxysmal neuropathic pain,
      with no other obvious clinical features. And bi-allelic non-functional
      mutations cause congenital painlessness, with the only other consequence
      being anosmia.
    explanation: Supports SCN9A loss of function as the canonical Nav1.7-related painless channelopathy.
  downstream:
  - target: Impaired nociceptor excitability
    description: >-
      Loss of Nav1.7 function leaves nociceptors present but unable to transmit
      normal warning signals.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:32219415
      reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Individuals with second type of CIP are born with nociceptors that are
        unable to be activated by tissue-damage signals,
      explanation: Directly links channelopathy-associated CIP to failed nociceptor activation.
  - target: Anosmia
    description: >-
      SCN9A loss-of-function channelopathy causes congenital painlessness with
      anosmia as the characteristic additional feature.
    causal_link_type: DIRECT
- name: Nav1.9 depolarization-block channelopathy
  conforms_to: "nociceptor_sodium_channel_excitability#Sustained Nociceptor Depolarization and Conduction Block"
  description: >-
    SCN11A-associated CIP is a paradoxical gain-of-function state in which
    excessive resting activity of Nav1.9 depolarizes nociceptors and blocks
    productive action-potential firing.
  genes:
  - preferred_term: SCN11A
    term:
      id: hgnc:10583
      label: SCN11A
  cell_types:
  - preferred_term: Nociceptor
    term:
      id: CL:0000198
      label: pain receptor cell
  biological_processes:
  - preferred_term: membrane depolarization
    modifier: ABNORMAL
    term:
      id: GO:0051899
      label: membrane depolarization
  evidence:
  - reference: PMID:24036948
    reference_title: "A de novo gain-of-function mutation in SCN11A causes loss of pain perception."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Mutant Nav1.9 channels displayed excessive activity at resting voltages,
      causing sustained depolarization of nociceptors, impaired generation of
      action potentials and aberrant synaptic transmission.
    explanation: Defines the Nav1.9 depolarization-block mechanism as an atomic SCN11A node.
  downstream:
  - target: Impaired nociceptor excitability
    description: >-
      Sustained depolarization prevents normal action-potential generation in
      nociceptors.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:24036948
      reference_title: "A de novo gain-of-function mutation in SCN11A causes loss of pain perception."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Mutant Nav1.9 channels displayed excessive activity at resting voltages,
        causing sustained depolarization of nociceptors, impaired generation of
        action potentials and aberrant synaptic transmission.
      explanation: Directly links the Nav1.9 defect to failed nociceptor firing.
- name: Impaired nociceptor excitability
  conforms_to: "nociceptor_sodium_channel_excitability#Nociceptor Action Potential Threshold and Firing"
  description: >-
    In channelopathy-associated CIP, nociceptors are present but electrically
    unable to generate or propagate appropriate warning signals.
  genes:
  - preferred_term: SCN9A
    term:
      id: hgnc:10597
      label: SCN9A
  - preferred_term: SCN11A
    term:
      id: hgnc:10583
      label: SCN11A
  cell_types:
  - preferred_term: Nociceptor
    term:
      id: CL:0000198
      label: pain receptor cell
  biological_processes:
  - preferred_term: regulation of membrane potential
    modifier: ABNORMAL
    term:
      id: GO:0042391
      label: regulation of membrane potential
  evidence:
  - reference: PMID:32219415
    reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Individuals with second type of CIP are born with nociceptors that are
      unable to be activated by tissue-damage signals,
    explanation: Shared review evidence for the preserved-but-electrically-silent nociceptor model.
  downstream:
  - target: Loss of protective pain perception
    description: >-
      Failure of nociceptor firing abolishes warning pain despite preserved
      neuronal anatomy.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:32219415
      reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Congenital insensitivity to pain (CIP) is an extremely rare human
        phenotype where no pain of any type is experienced during an affected
        individuals’ lifetime.
      explanation: Connects excitability failure to the shared analgesic phenotype.
- name: Impaired NGF-TRKA-dependent macrophage killing
  description: >-
    Developmental NGF-TRKA CIP forms also weaken macrophage-mediated host
    defense against Staphylococcus aureus.
  genes:
  - preferred_term: NTRK1
    term:
      id: hgnc:8031
      label: NTRK1
  - preferred_term: NGF
    term:
      id: hgnc:7808
      label: NGF
  cell_types:
  - preferred_term: Macrophage
    term:
      id: CL:0000235
      label: macrophage
  biological_processes:
  - preferred_term: phagocytosis
    modifier: DECREASED
    term:
      id: GO:0006909
      label: phagocytosis
  evidence:
  - reference: PMID:32219415
    reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Increased susceptibility to Staphylococcus aureus infection is a
      consequence of deficient NGF-TRKA signalling.
    explanation: Supports a distinct macrophage host-defense defect in developmental CIP.
  downstream:
  - target: Staphylococcus aureus infection susceptibility
    description: >-
      Reduced macrophage killing capacity predisposes to recurrent deep and
      skin infections in developmental CIP forms.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:32219415
      reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Distinctive to HSANs is a significant susceptibility to Staphylococcus
        aureus infections manifest as grumbling skin infections,
        osteomyelitis and septic arthritis.
      explanation: Directly links defective NGF-TRKA macrophage signaling to the clinical infection phenotype.
- name: Staphylococcus aureus infection susceptibility
  description: >-
    Developmental CIP forms, but not channelopathy-associated forms, show a
    distinctive propensity to osteomyelitis, septic arthritis, and skin
    infection with Staphylococcus aureus.
  subtypes:
  - HSAN IV
  - HSAN V
  - HSAN VIII
  evidence:
  - reference: PMID:32219415
    reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Distinctive to HSANs is a significant susceptibility to Staphylococcus
      aureus infections manifest as grumbling skin infections, osteomyelitis
      and septic arthritis.
    explanation: Captures the clinically important infection susceptibility of developmental CIP forms.
  downstream:
  - target: Osteomyelitis
    description: >-
      Staphylococcus aureus susceptibility in developmental CIP can manifest as
      osteomyelitis.
    causal_link_type: DIRECT
- name: Loss of protective pain perception
  description: >-
    Both structural denervation and channelopathic firing failure converge on
    the same final phenotype: absent protective pain responses with severe
    injury-related morbidity.
  cell_types:
  - preferred_term: Nociceptor
    term:
      id: CL:0000198
      label: pain receptor cell
  biological_processes:
  - preferred_term: sensory perception of pain
    modifier: DECREASED
    term:
      id: GO:0019233
      label: sensory perception of pain
  evidence:
  - reference: PMID:32219415
    reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Congenital insensitivity to pain (CIP) is an extremely rare human
      phenotype where no pain of any type is experienced during an affected
      individuals’ lifetime.
    explanation: Defines the shared final phenotype across all grouped CIP branches.
  downstream:
  - target: Pain insensitivity
    description: >-
      Loss of protective pain perception is the defining pain-insensitivity
      phenotype.
    causal_link_type: DIRECT
  - target: Self-mutilation
    description: >-
      Absent protective pain sensation permits repetitive biting and tissue
      injury without normal warning pain.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
  - target: Neuropathic arthropathy
    description: >-
      Repetitive painless joint injury leads to Charcot-joint arthropathy and
      progressive orthopedic damage.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
- name: ZFHX2-dependent transcriptional programme deregulation in nociceptors
  biological_scale: MOLECULAR
  description: >-
    The Marsili-type lesion. ZFHX2 encodes a transcriptional regulator expressed
    in small diameter sensory neurons; the homeodomain arginine substitution
    found in the affected family deregulates expression of genes implicated in
    peripheral pain mechanisms in dorsal root ganglia. Unlike the PRDM12 and
    NGF-TRKA branches, the nociceptors themselves are not lost — the reported
    disorder is explicitly not associated with a peripheral neuropathy — so the
    claim here is a change in the programme those surviving neurons express.
  cell_types:
  - preferred_term: nociceptor
    term:
      id: CL:0000198
      label: pain receptor cell
  biological_processes:
  - preferred_term: regulation of gene expression
    term:
      id: GO:0010468
      label: regulation of gene expression
    modifier: DYSREGULATED
  genes:
  - preferred_term: ZFHX2
    term:
      id: hgnc:20152
      label: ZFHX2
  downstream:
  - target: Loss of protective pain perception
    description: >-
      Deregulated expression of pain-related genes in dorsal root ganglion
      neurons reduces pain sensitivity without removing the neurons, which is the
      route from the ZFHX2 lesion to the shared loss of protective pain
      perception in this entry.
  evidence:
  - reference: PMID:29253101
    reference_title: A novel human pain insensitivity disorder caused by a point mutation in ZFHX2.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Gene expression analyses in dorsal root ganglia from mutant and wild-type mice show altered expression of genes implicated in peripheral pain mechanisms."
    explanation: >-
      The measurement behind this node: mutant dorsal root ganglia show altered
      expression of pain-related genes, which is the dysregulated
      gene-expression claim bound here.
  - reference: PMID:29253101
    reference_title: A novel human pain insensitivity disorder caused by a point mutation in ZFHX2.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A novel point mutation in ZFHX2, encoding a putative transcription factor expressed in small diameter sensory neurons, was identified by whole exome sequencing that segregates with the pain insensitivity."
    explanation: >-
      Supports the cell type bound on this node — small diameter sensory neurons —
      and the identity of ZFHX2 as a transcription factor.
  - reference: PMID:29253101
    reference_title: A novel human pain insensitivity disorder caused by a point mutation in ZFHX2.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This autosomal dominant disorder is found in three generations and is not associated with a peripheral neuropathy."
    explanation: >-
      Source for the distinction this node draws from the developmental branches:
      there is no peripheral neuropathy, so the nociceptors are not lost.
phenotypes:
- category: Neurological
  name: Pain insensitivity
  diagnostic: true
  description: >-
    Shared defining phenotype across the grouped CIP disorders, reflecting loss
    of protective pain sensation from birth.
  phenotype_term:
    preferred_term: Congenital insensitivity to pain
    term:
      id: HP:0007021
      label: Pain insensitivity
  evidence:
  - reference: PMID:32219415
    reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Congenital insensitivity to pain (CIP) is an extremely rare human
      phenotype where no pain of any type is experienced during an affected
      individuals’ lifetime.
    explanation: Supports the core umbrella phenotype of absent pain sensation.
- category: Behavioral
  name: Self-mutilation
  description: >-
    Early repetitive biting and tissue injury are common consequences of absent
    protective pain sensation, especially after teething.
  phenotype_term:
    preferred_term: Self-mutilation
    term:
      id: HP:0000742
      label: Self-mutilation
  evidence:
  - reference: PMID:32219415
    reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Coincident with teething in the first year of life, self-mutilation of
      lips, tongue, fingers and toes often occur.
    explanation: Supports self-injury as a recurrent shared consequence of CIP.
- category: Musculoskeletal
  name: Neuropathic arthropathy
  description: >-
    Repetitive painless joint injury leads to Charcot-joint deformity and
    progressive orthopedic damage.
  phenotype_term:
    preferred_term: Neuropathic arthropathy (Charcot joint)
    term:
      id: HP:0002821
      label: Neuropathic arthropathy
  evidence:
  - reference: PMID:32219415
    reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Long bone fractures can heal, if allowed to do so, but it is the joint
      injuries that inevitably lead to Charcot’s joints, and hence progressive
      orthopaedic deformities.
    explanation: Supports Charcot-joint arthropathy as a shared morbidity of CIP.
- category: Neurological
  name: Anosmia
  subtype: SCN9A AR-CIP
  description: >-
    Congenital anosmia is the characteristic associated feature of the SCN9A
    channelopathy branch.
  phenotype_term:
    preferred_term: Anosmia
    term:
      id: HP:0000458
      label: Anosmia
  evidence:
  - reference: PMID:32219415
    reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      In CIP-SCN9A the only additional feature is congenital anosmia
      (absence of the sense of smell),
    explanation: Supports anosmia as the distinguishing SCN9A-associated phenotype.
- category: Neurological
  name: Intellectual disability
  subtype: HSAN IV
  description: >-
    Cognitive impairment is documented in classic NTRK1-related CIPA and helps
    distinguish HSAN IV from some other CIP subtypes.
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  evidence:
  - reference: PMID:16138253
    reference_title: >-
      Congenital insensitivity to pain with Anhidrosis (NTRK1 mutation) and
      early onset renal disease: clinical report on three sibs with a 25-year
      follow-up in one of them.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      They had the characteristic clinical features of an abnormally high pain
      threshold, and mental retardation;
    explanation: Supports intellectual disability as a documented HSAN IV feature.
- category: Infectious
  name: Osteomyelitis
  subtypes:
  - HSAN IV
  - HSAN V
  - HSAN VIII
  description: >-
    Developmental CIP forms show susceptibility to Staphylococcus aureus
    osteomyelitis and related deep infections.
  phenotype_term:
    preferred_term: Osteomyelitis
    term:
      id: HP:0002754
      label: Osteomyelitis
  evidence:
  - reference: PMID:32219415
    reference_title: "Understanding the genetic basis of congenital insensitivity to pain."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Distinctive to HSANs is a significant susceptibility to Staphylococcus
      aureus infections manifest as grumbling skin infections, osteomyelitis
      and septic arthritis.
    explanation: Captures osteomyelitis as a distinctive complication of developmental CIP branches.
📚

References & Deep Research

References

6
Congenital Insensitivity to Pain Overview.
No top-level findings curated for this source.
NTRK1 Congenital Insensitivity to Pain with Anhidrosis.
No top-level findings curated for this source.
Understanding the genetic basis of congenital insensitivity to pain.
1 finding
Congenital insensitivity to pain (CIP) is caused by extremely rare Mendelian genetic disorders.
"Congenital insensitivity to pain (CIP) is caused by extremely rare Mendelian genetic disorders."
Congenital insensitivity to pain with Anhidrosis (NTRK1 mutation) and early onset renal disease: clinical report on three sibs with a 25-year follow-up in one of them.
1 finding
Congenital insensitivity to pain with anhidrosis (CIPA) is an autosomal recessive disorder caused by mutations in the neurotrophic tyrosine receptor kinase 1 (NTRK1) gene which encodes the receptor for nerve growth factor (NGF).
"Congenital insensitivity to pain with anhidrosis (CIPA) is an autosomal recessive disorder caused by mutations in the neurotrophic tyrosine receptor kinase 1 (NTRK1) gene which encodes the receptor for nerve growth factor (NGF)."
A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception.
1 finding
Clinically they best fit into HSAN V.
"Clinically they best fit into HSAN V."
A de novo gain-of-function mutation in SCN11A causes loss of pain perception.
1 finding
Using exome sequencing, we identified a specific de novo missense mutation in SCN11A in individuals with the congenital inability to experience pain who suffer from recurrent tissue damage and severe mutilations.
"Using exome sequencing, we identified a specific de novo missense mutation in SCN11A in individuals with the congenital inability to experience pain who suffer from recurrent tissue damage and severe mutilations."

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Congenital Insensitivity to Pain Deep Research Notes ▸

Congenital Insensitivity to Pain Deep Research Notes

Modeling choices applied from PR review

  • This revision treats congenital insensitivity to pain as a thin phenotype-grouping page, not as a claim that all CIP branches are one cleanly unified disease entity.
  • I did not split this PR into five standalone subtype pages because that would require a larger ontology and evidence expansion than the review was asking for. Instead, I trimmed the umbrella and made the shared pathograph explicit.
  • The ontology anchor remains MONDO:0015364 (hereditary sensory and autonomic neuropathy) only because the exact umbrella term requested in MONDO NTR #10031 is not yet available.
  • Subtype-specific disease identity is retained through child MONDO terms for NTRK1 / HSAN IV, NGF / HSAN V, SCN9A AR-CIP, SCN11A / HSAN VII, and PRDM12 / HSAN VIII.

Disease identity and scope

  • PMID:32219415
  • Evidence source: OTHER
  • Quote:

    Congenital insensitivity to pain (CIP) is caused by extremely rare Mendelian genetic disorders.

  • Curation implication: This page is valid as a phenotype grouping, but the plural "disorders" argues against treating it as a single mechanistic disease record.

Mechanistic synthesis used in the YAML curation

1. PRDM12-dependent nociceptor specification is upstream and distinct

  • PMID:32219415
  • Evidence source: OTHER
  • Quote:

    PRDM12 and CLTCL1 are important in the differentiation from a neural crest cell to a precursor sensory neuron.

  • PMID:32219415
  • Evidence source: OTHER
  • Quote:

    The recent finding that PRDM12 activated NTRK1 expression in nociceptor precursors further cemented the absolute importance of NGF-TRKA signalling for nociceptor genesis.

  • Curation implication: I split PRDM12-related specification failure into its own atomic node upstream of NGF-TRKA trophic signaling rather than hiding it inside a bundled developmental umbrella.

2. NGF-TRKA trophic failure and developmental apoptosis are separate steps

  • PMID:32219415
  • Evidence source: OTHER
  • Quote:

    The importance of nerve growth factor-tropomyosin receptor kinase A (NGF-TRKA) signalling for nociceptor genesis and subsequent pain sensing.

  • PMID:32219415
  • Evidence source: OTHER
  • Quote:

    CIP can be clinically divided into two groups: developmental disorders where nociceptors fail to develop or undergo early apoptosis through lack of trophic signals;

  • PMID:14976160
  • Evidence source: HUMAN_CLINICAL
  • Quote:

    A severe reduction of unmyelinated nerve fibers and a moderate loss of thin myelinated nerve fibers are observed in the patients.

  • Curation implication: The YAML now separates trophic signaling failure, developmental apoptosis, and reduced small-fiber innervation into distinct nodes with explicit downstream links.

3. SCN9A and SCN11A are grouped only at the level of impaired excitability

  • PMID:32219415
  • Evidence source: OTHER
  • Quote:

    So, activating mutations in SCN9A produce paroxysmal neuropathic pain, with no other obvious clinical features. And bi-allelic non-functional mutations cause congenital painlessness, with the only other consequence being anosmia.

  • PMID:24036948
  • Evidence source: HUMAN_CLINICAL
  • Quote:

    Mutant Nav1.9 channels displayed excessive activity at resting voltages, causing sustained depolarization of nociceptors, impaired generation of action potentials and aberrant synaptic transmission.

  • Curation implication: I kept SCN9A and SCN11A as separate atomic channelopathy nodes and only converged them downstream at "Impaired nociceptor excitability" and then "Loss of protective pain perception".

4. Shared morbidity belongs on the grouping page

  • PMID:32219415
  • Evidence source: OTHER
  • Quote:

    Coincident with teething in the first year of life, self-mutilation of lips, tongue, fingers and toes often occur.

  • PMID:32219415
  • Evidence source: OTHER
  • Quote:

    Long bone fractures can heal, if allowed to do so, but it is the joint injuries that inevitably lead to Charcot’s joints, and hence progressive orthopaedic deformities.

  • Curation implication: These findings support keeping a small phenotypes block on the grouping page even though detailed natural history should eventually move to subtype pages.

5. Developmental CIP has a distinctive Staphylococcus aureus complication axis

  • PMID:32219415
  • Evidence source: OTHER
  • Quote:

    Increased susceptibility to Staphylococcus aureus infection is a consequence of deficient NGF-TRKA signalling.

  • PMID:32219415
  • Evidence source: OTHER
  • Quote:

    Distinctive to HSANs is a significant susceptibility to Staphylococcus aureus infections manifest as grumbling skin infections, osteomyelitis and septic arthritis.

  • Curation implication: The revised YAML now includes a macrophage-centered pathophysiology node and a developmental-subtype osteomyelitis phenotype so this clinically important complication is not lost.

6. HSAN IV should explicitly carry cognitive impairment

  • PMID:16138253
  • Evidence source: HUMAN_CLINICAL
  • Quote:

    They had the characteristic clinical features of an abnormally high pain threshold, and mental retardation;

  • PMID:14976160
  • Evidence source: HUMAN_CLINICAL
  • Quote:

    The loss of pain perception in this family is characterized by impairment in the sensing of deep pain and temperature but with normal mental abilities and with most other neurological responses intact.

  • Curation implication: I added Intellectual disability specifically to the HSAN IV branch and left HSAN V described as cognitively relatively preserved.

Deliberate omissions in this revision

  • I did not add umbrella-level treatments because management is heavily driven by injury surveillance, orthopedic complications, ocular protection, and subtype-specific autonomic issues rather than one shared mechanism-directed therapy.
  • I did not create standalone subtype files in this PR; the current revision is intended to satisfy the review by making the grouping page thinner and more explicit, not by performing a full subtype decomposition.